Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATCH-AF: Ablation vs Medical Therapy in Heart Failure
NCT02686749Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- Jun 2016
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Cleveland Clinic. Primary endpoint: First Hospitalization for Heart Failure, Recurrence of AF or Direct Current Cardioversion at 12 months. Started Jun 2016; status: terminated.
Beyond the preview
Go deeper on NCT02686749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686749.